Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein

rBPI23is a biologically active, recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI). While rBPI23is readily purified from culture supernatants of Chinese hamster ovary (CHO)-K1 transfectants, it is heterogeneous, consisting of monomer and disulfide-linked dime...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Protein expression and purification 1996-08, Vol.8 (1), p.28-40
Hauptverfasser: Horwitz, Arnold H., Leigh, Scott D., Abrahamson, Susan, Gazzano-Santoro, Hélène, Liu, Pei-Syan, Williams, Robert E., Carroll, Stephen F., Theofan, Georgia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 40
container_issue 1
container_start_page 28
container_title Protein expression and purification
container_volume 8
creator Horwitz, Arnold H.
Leigh, Scott D.
Abrahamson, Susan
Gazzano-Santoro, Hélène
Liu, Pei-Syan
Williams, Robert E.
Carroll, Stephen F.
Theofan, Georgia
description rBPI23is a biologically active, recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI). While rBPI23is readily purified from culture supernatants of Chinese hamster ovary (CHO)-K1 transfectants, it is heterogeneous, consisting of monomer and disulfide-linked dimer, characteristics due presumably to the presence of three cysteines within the molecule. We have examined the role of these cysteines in rBPI23expression, function, and dimer formation by mutating their codons to alanine (C132A), serine (C135S), or alanine (C175A) and expressing analogues of N-terminal fragments (“variants”) lacking one, two, or all three cysteines in permanently transfected CHO-K1 cells. We also expressed a variant in which serine 18 was changed to cysteine (S18C), as found in both bovine and rabbit BPI. The C132A variant was readily secreted and purified as a homogeneous, stable monomeric protein species. The C135S and S18C variants were produced as mixtures of monomer and dimer; the C135S variant was poorly secreted, difficult to purify, and unstable on storage. In contrast, the C175A variant and those lacking any two or all three cysteines were expressed but not secreted. Purified rBPI23and the C132A and S18C variants had comparable bactericidal and lipopolysaccharide (LPS) binding activities and were similarly effective at neutralizing LPS-induced tumor necrosis factor synthesis by THP-1 cells; the purified C135S variant lacked all activities. From these studies with CHO-K1 transfectants, we conclude that (i) cysteines 135 and 175 are both necessary for efficient secretion of a biologically active N-terminal BPI fragment, presumably through the formation of a disulfide bond, (ii) cysteine 132 is responsible for dimer formation, and (iii) only the C132A modification yields a stable, biologically active, N-terminal BPI fragment (designated rBPI21) that is free of dimeric species.
doi_str_mv 10.1006/prep.1996.0071
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1006_prep_1996_0071</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1046592896900716</els_id><sourcerecordid>S1046592896900716</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-83526eed7796f1176a6308137320f7e617840ae48879b27e3825ef2b3e49086c3</originalsourceid><addsrcrecordid>eNp1kEFOwzAQRS0EKqWwZYeUCyS1ncR2lqVqoVIRXRS2keNMilHiRHZAlCtwaWKlYsdqRvP__Bk9hG4JjgjGbN5Z6CKSZSzCmJMzNCU4YyGmPDv3fcLCNKPiEl05944xIQynEzQRglAR0yn6WX0NCc7p1gTSlMHyTVqperD6W_Z-2FbB8uh60AbCp7bUlYYyeJVWS9M7r0oTLBpt2nAPdqiyDtZWHhowvVfvxzClS1nPd4MDZKFr3R_DjVEWpNPmEOxs6w9co4tK1g5uTnWGXtar_fIx3D4_bJaLbagSnPahiFPKAErOM1YRwplkMRYk5jHFFQdGuEiwhEQInhWUQyxoChUtYkgyLJiKZygac5VtnbNQ5Z3VjbTHnODcQ8091NxDzT3UYeFuXOg-igbKP_uJ4qCLUYfh608NNndKg1FQaguqz8tW_xf9C1kyiAs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Horwitz, Arnold H. ; Leigh, Scott D. ; Abrahamson, Susan ; Gazzano-Santoro, Hélène ; Liu, Pei-Syan ; Williams, Robert E. ; Carroll, Stephen F. ; Theofan, Georgia</creator><creatorcontrib>Horwitz, Arnold H. ; Leigh, Scott D. ; Abrahamson, Susan ; Gazzano-Santoro, Hélène ; Liu, Pei-Syan ; Williams, Robert E. ; Carroll, Stephen F. ; Theofan, Georgia</creatorcontrib><description>rBPI23is a biologically active, recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI). While rBPI23is readily purified from culture supernatants of Chinese hamster ovary (CHO)-K1 transfectants, it is heterogeneous, consisting of monomer and disulfide-linked dimer, characteristics due presumably to the presence of three cysteines within the molecule. We have examined the role of these cysteines in rBPI23expression, function, and dimer formation by mutating their codons to alanine (C132A), serine (C135S), or alanine (C175A) and expressing analogues of N-terminal fragments (“variants”) lacking one, two, or all three cysteines in permanently transfected CHO-K1 cells. We also expressed a variant in which serine 18 was changed to cysteine (S18C), as found in both bovine and rabbit BPI. The C132A variant was readily secreted and purified as a homogeneous, stable monomeric protein species. The C135S and S18C variants were produced as mixtures of monomer and dimer; the C135S variant was poorly secreted, difficult to purify, and unstable on storage. In contrast, the C175A variant and those lacking any two or all three cysteines were expressed but not secreted. Purified rBPI23and the C132A and S18C variants had comparable bactericidal and lipopolysaccharide (LPS) binding activities and were similarly effective at neutralizing LPS-induced tumor necrosis factor synthesis by THP-1 cells; the purified C135S variant lacked all activities. From these studies with CHO-K1 transfectants, we conclude that (i) cysteines 135 and 175 are both necessary for efficient secretion of a biologically active N-terminal BPI fragment, presumably through the formation of a disulfide bond, (ii) cysteine 132 is responsible for dimer formation, and (iii) only the C132A modification yields a stable, biologically active, N-terminal BPI fragment (designated rBPI21) that is free of dimeric species.</description><identifier>ISSN: 1046-5928</identifier><identifier>EISSN: 1096-0279</identifier><identifier>DOI: 10.1006/prep.1996.0071</identifier><identifier>PMID: 8812832</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Anti-Infective Agents - pharmacology ; Antimicrobial Cationic Peptides ; Binding, Competitive ; Blood Proteins - chemistry ; Blood Proteins - genetics ; Blood Proteins - isolation &amp; purification ; Blotting, Northern ; Blotting, Western ; Carrier Proteins - metabolism ; CHO Cells ; Cricetinae ; Cysteine - genetics ; Cysteine - metabolism ; Disulfides - metabolism ; Electrophoresis, Polyacrylamide Gel ; Heat-Shock Proteins ; Humans ; Lipopolysaccharides - pharmacology ; Membrane Proteins ; Molecular Chaperones - metabolism ; Mutagenesis, Site-Directed - genetics ; Protein Conformation ; Protein Folding ; Recombinant Proteins - chemistry ; Recombinant Proteins - isolation &amp; purification ; Recombinant Proteins - metabolism ; Sulfhydryl Compounds - metabolism ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Protein expression and purification, 1996-08, Vol.8 (1), p.28-40</ispartof><rights>1996 Academic Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-83526eed7796f1176a6308137320f7e617840ae48879b27e3825ef2b3e49086c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/prep.1996.0071$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8812832$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Horwitz, Arnold H.</creatorcontrib><creatorcontrib>Leigh, Scott D.</creatorcontrib><creatorcontrib>Abrahamson, Susan</creatorcontrib><creatorcontrib>Gazzano-Santoro, Hélène</creatorcontrib><creatorcontrib>Liu, Pei-Syan</creatorcontrib><creatorcontrib>Williams, Robert E.</creatorcontrib><creatorcontrib>Carroll, Stephen F.</creatorcontrib><creatorcontrib>Theofan, Georgia</creatorcontrib><title>Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein</title><title>Protein expression and purification</title><addtitle>Protein Expr Purif</addtitle><description>rBPI23is a biologically active, recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI). While rBPI23is readily purified from culture supernatants of Chinese hamster ovary (CHO)-K1 transfectants, it is heterogeneous, consisting of monomer and disulfide-linked dimer, characteristics due presumably to the presence of three cysteines within the molecule. We have examined the role of these cysteines in rBPI23expression, function, and dimer formation by mutating their codons to alanine (C132A), serine (C135S), or alanine (C175A) and expressing analogues of N-terminal fragments (“variants”) lacking one, two, or all three cysteines in permanently transfected CHO-K1 cells. We also expressed a variant in which serine 18 was changed to cysteine (S18C), as found in both bovine and rabbit BPI. The C132A variant was readily secreted and purified as a homogeneous, stable monomeric protein species. The C135S and S18C variants were produced as mixtures of monomer and dimer; the C135S variant was poorly secreted, difficult to purify, and unstable on storage. In contrast, the C175A variant and those lacking any two or all three cysteines were expressed but not secreted. Purified rBPI23and the C132A and S18C variants had comparable bactericidal and lipopolysaccharide (LPS) binding activities and were similarly effective at neutralizing LPS-induced tumor necrosis factor synthesis by THP-1 cells; the purified C135S variant lacked all activities. From these studies with CHO-K1 transfectants, we conclude that (i) cysteines 135 and 175 are both necessary for efficient secretion of a biologically active N-terminal BPI fragment, presumably through the formation of a disulfide bond, (ii) cysteine 132 is responsible for dimer formation, and (iii) only the C132A modification yields a stable, biologically active, N-terminal BPI fragment (designated rBPI21) that is free of dimeric species.</description><subject>Animals</subject><subject>Anti-Infective Agents - pharmacology</subject><subject>Antimicrobial Cationic Peptides</subject><subject>Binding, Competitive</subject><subject>Blood Proteins - chemistry</subject><subject>Blood Proteins - genetics</subject><subject>Blood Proteins - isolation &amp; purification</subject><subject>Blotting, Northern</subject><subject>Blotting, Western</subject><subject>Carrier Proteins - metabolism</subject><subject>CHO Cells</subject><subject>Cricetinae</subject><subject>Cysteine - genetics</subject><subject>Cysteine - metabolism</subject><subject>Disulfides - metabolism</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>Heat-Shock Proteins</subject><subject>Humans</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Membrane Proteins</subject><subject>Molecular Chaperones - metabolism</subject><subject>Mutagenesis, Site-Directed - genetics</subject><subject>Protein Conformation</subject><subject>Protein Folding</subject><subject>Recombinant Proteins - chemistry</subject><subject>Recombinant Proteins - isolation &amp; purification</subject><subject>Recombinant Proteins - metabolism</subject><subject>Sulfhydryl Compounds - metabolism</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>1046-5928</issn><issn>1096-0279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEFOwzAQRS0EKqWwZYeUCyS1ncR2lqVqoVIRXRS2keNMilHiRHZAlCtwaWKlYsdqRvP__Bk9hG4JjgjGbN5Z6CKSZSzCmJMzNCU4YyGmPDv3fcLCNKPiEl05944xIQynEzQRglAR0yn6WX0NCc7p1gTSlMHyTVqperD6W_Z-2FbB8uh60AbCp7bUlYYyeJVWS9M7r0oTLBpt2nAPdqiyDtZWHhowvVfvxzClS1nPd4MDZKFr3R_DjVEWpNPmEOxs6w9co4tK1g5uTnWGXtar_fIx3D4_bJaLbagSnPahiFPKAErOM1YRwplkMRYk5jHFFQdGuEiwhEQInhWUQyxoChUtYkgyLJiKZygac5VtnbNQ5Z3VjbTHnODcQ8091NxDzT3UYeFuXOg-igbKP_uJ4qCLUYfh608NNndKg1FQaguqz8tW_xf9C1kyiAs</recordid><startdate>19960801</startdate><enddate>19960801</enddate><creator>Horwitz, Arnold H.</creator><creator>Leigh, Scott D.</creator><creator>Abrahamson, Susan</creator><creator>Gazzano-Santoro, Hélène</creator><creator>Liu, Pei-Syan</creator><creator>Williams, Robert E.</creator><creator>Carroll, Stephen F.</creator><creator>Theofan, Georgia</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19960801</creationdate><title>Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein</title><author>Horwitz, Arnold H. ; Leigh, Scott D. ; Abrahamson, Susan ; Gazzano-Santoro, Hélène ; Liu, Pei-Syan ; Williams, Robert E. ; Carroll, Stephen F. ; Theofan, Georgia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-83526eed7796f1176a6308137320f7e617840ae48879b27e3825ef2b3e49086c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Anti-Infective Agents - pharmacology</topic><topic>Antimicrobial Cationic Peptides</topic><topic>Binding, Competitive</topic><topic>Blood Proteins - chemistry</topic><topic>Blood Proteins - genetics</topic><topic>Blood Proteins - isolation &amp; purification</topic><topic>Blotting, Northern</topic><topic>Blotting, Western</topic><topic>Carrier Proteins - metabolism</topic><topic>CHO Cells</topic><topic>Cricetinae</topic><topic>Cysteine - genetics</topic><topic>Cysteine - metabolism</topic><topic>Disulfides - metabolism</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>Heat-Shock Proteins</topic><topic>Humans</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Membrane Proteins</topic><topic>Molecular Chaperones - metabolism</topic><topic>Mutagenesis, Site-Directed - genetics</topic><topic>Protein Conformation</topic><topic>Protein Folding</topic><topic>Recombinant Proteins - chemistry</topic><topic>Recombinant Proteins - isolation &amp; purification</topic><topic>Recombinant Proteins - metabolism</topic><topic>Sulfhydryl Compounds - metabolism</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horwitz, Arnold H.</creatorcontrib><creatorcontrib>Leigh, Scott D.</creatorcontrib><creatorcontrib>Abrahamson, Susan</creatorcontrib><creatorcontrib>Gazzano-Santoro, Hélène</creatorcontrib><creatorcontrib>Liu, Pei-Syan</creatorcontrib><creatorcontrib>Williams, Robert E.</creatorcontrib><creatorcontrib>Carroll, Stephen F.</creatorcontrib><creatorcontrib>Theofan, Georgia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Protein expression and purification</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horwitz, Arnold H.</au><au>Leigh, Scott D.</au><au>Abrahamson, Susan</au><au>Gazzano-Santoro, Hélène</au><au>Liu, Pei-Syan</au><au>Williams, Robert E.</au><au>Carroll, Stephen F.</au><au>Theofan, Georgia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein</atitle><jtitle>Protein expression and purification</jtitle><addtitle>Protein Expr Purif</addtitle><date>1996-08-01</date><risdate>1996</risdate><volume>8</volume><issue>1</issue><spage>28</spage><epage>40</epage><pages>28-40</pages><issn>1046-5928</issn><eissn>1096-0279</eissn><abstract>rBPI23is a biologically active, recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI). While rBPI23is readily purified from culture supernatants of Chinese hamster ovary (CHO)-K1 transfectants, it is heterogeneous, consisting of monomer and disulfide-linked dimer, characteristics due presumably to the presence of three cysteines within the molecule. We have examined the role of these cysteines in rBPI23expression, function, and dimer formation by mutating their codons to alanine (C132A), serine (C135S), or alanine (C175A) and expressing analogues of N-terminal fragments (“variants”) lacking one, two, or all three cysteines in permanently transfected CHO-K1 cells. We also expressed a variant in which serine 18 was changed to cysteine (S18C), as found in both bovine and rabbit BPI. The C132A variant was readily secreted and purified as a homogeneous, stable monomeric protein species. The C135S and S18C variants were produced as mixtures of monomer and dimer; the C135S variant was poorly secreted, difficult to purify, and unstable on storage. In contrast, the C175A variant and those lacking any two or all three cysteines were expressed but not secreted. Purified rBPI23and the C132A and S18C variants had comparable bactericidal and lipopolysaccharide (LPS) binding activities and were similarly effective at neutralizing LPS-induced tumor necrosis factor synthesis by THP-1 cells; the purified C135S variant lacked all activities. From these studies with CHO-K1 transfectants, we conclude that (i) cysteines 135 and 175 are both necessary for efficient secretion of a biologically active N-terminal BPI fragment, presumably through the formation of a disulfide bond, (ii) cysteine 132 is responsible for dimer formation, and (iii) only the C132A modification yields a stable, biologically active, N-terminal BPI fragment (designated rBPI21) that is free of dimeric species.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>8812832</pmid><doi>10.1006/prep.1996.0071</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1046-5928
ispartof Protein expression and purification, 1996-08, Vol.8 (1), p.28-40
issn 1046-5928
1096-0279
language eng
recordid cdi_crossref_primary_10_1006_prep_1996_0071
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Animals
Anti-Infective Agents - pharmacology
Antimicrobial Cationic Peptides
Binding, Competitive
Blood Proteins - chemistry
Blood Proteins - genetics
Blood Proteins - isolation & purification
Blotting, Northern
Blotting, Western
Carrier Proteins - metabolism
CHO Cells
Cricetinae
Cysteine - genetics
Cysteine - metabolism
Disulfides - metabolism
Electrophoresis, Polyacrylamide Gel
Heat-Shock Proteins
Humans
Lipopolysaccharides - pharmacology
Membrane Proteins
Molecular Chaperones - metabolism
Mutagenesis, Site-Directed - genetics
Protein Conformation
Protein Folding
Recombinant Proteins - chemistry
Recombinant Proteins - isolation & purification
Recombinant Proteins - metabolism
Sulfhydryl Compounds - metabolism
Tumor Necrosis Factor-alpha - metabolism
title Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T08%3A37%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20and%20Characterization%20of%20Cysteine-Modified%20Variants%20of%20an%20Amino-Terminal%20Fragment%20of%20Bactericidal/Permeability-Increasing%20Protein&rft.jtitle=Protein%20expression%20and%20purification&rft.au=Horwitz,%20Arnold%20H.&rft.date=1996-08-01&rft.volume=8&rft.issue=1&rft.spage=28&rft.epage=40&rft.pages=28-40&rft.issn=1046-5928&rft.eissn=1096-0279&rft_id=info:doi/10.1006/prep.1996.0071&rft_dat=%3Celsevier_cross%3ES1046592896900716%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/8812832&rft_els_id=S1046592896900716&rfr_iscdi=true